{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:35Z","timestamp":1792788095601,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2023A1515220003"],"award-info":[{"award-number":["No. 2023A1515220003"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dongguan Science and Technology of Social Development Program","award":["No. 20231800935382"],"award-info":[{"award-number":["No. 20231800935382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01700-8","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:11:10Z","timestamp":1748841070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plumbagin ameliorates ferroptosis of ovarian granulosa cells in polycystic ovary syndrome by down-regulating SLC7A5 m6A methylation modification through inhibition of YTHDF1"],"prefix":"10.1186","volume":"18","author":[{"given":"ZhaoWei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuoPeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RongJu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiLing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"2","key":"1700_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","volume":"23","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022;23(2):583.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1700_CR2","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1210\/clinem\/dgab232","volume":"106","author":"BH Al Wattar","year":"2021","unstructured":"Al Wattar BH, Fisher M, Bevington L, Talaulikar V, Davies M, Conway G, et al. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J Clin Endocrinol Metab. 2021;106(8):2436\u201346.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1700_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1700_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7150\/thno.67167","volume":"12","author":"M Chen","year":"2022","unstructured":"Chen M, He C, Zhu K, Chen Z, Meng Z, Jiang X, et al. Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication. Theranostics. 2022;12(2):782\u201395.","journal-title":"Theranostics"},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.05.010","volume":"187","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Ren J, Wang F, Pan M, Cui L, Li M, et al. Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3. Free Radic Biol Med. 2022;187:1\u201316.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1700_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"1700_CR7","doi-asserted-by":"publisher","first-page":"e2315541121","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci U S A. 2024;121(16):e2315541121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1700_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/BST20230574","volume":"52","author":"G Wei","year":"2024","unstructured":"Wei G. RNA m6A modification, signals for degradation or stabilisation? Biochem Soc Trans. 2024;52(2):707\u201317.","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"1700_CR9","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1093\/plcell\/koae149","volume":"36","author":"Z Cai","year":"2024","unstructured":"Cai Z, Tang Q, Song P, Tian E, Yang J, Jia G. The m6A reader ECT8 is an abiotic stress sensor that accelerates mRNA decay in Arabidopsis. Plant Cell. 2024;36(8):2908\u201326.","journal-title":"Plant Cell"},{"issue":"6","key":"1700_CR10","doi-asserted-by":"publisher","first-page":"114369","DOI":"10.1016\/j.celrep.2024.114369","volume":"43","author":"S Garbo","year":"2024","unstructured":"Garbo S, D\u2019Andrea D, Colantoni A, Fiorentino F, Mai A, Ramos A, et al. m6A modification inhibits miRNAs\u2019 intracellular function, favoring their extracellular export for intercellular communication. Cell Rep. 2024;43(6):114369.","journal-title":"Cell Rep"},{"issue":"12","key":"1700_CR11","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1093\/nar\/gkae322","volume":"52","author":"M Rossi","year":"2024","unstructured":"Rossi M, Banskota N, Shin CH, Anerillas C, Tsitsipatis D, Yang JH, et al. Increased PTCHD4 expression via m6A modification of PTCHD4 mRNA promotes senescent cell survival. Nucleic Acids Res. 2024;52(12):7261\u201378.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"1700_CR12","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1158\/0008-5472.CAN-23-2081","volume":"84","author":"D Chen","year":"2024","unstructured":"Chen D, Ji F, Zhou Q, Cheung H, Pan Y, Lau HC, et al. RUVBL1\/2 Blockade Targets YTHDF1 activity to suppress m6A-dependent oncogenic translation and colorectal tumorigenesis. Cancer Res. 2024;84(17):2856\u201372.","journal-title":"Cancer Res"},{"issue":"9","key":"1700_CR13","doi-asserted-by":"publisher","first-page":"e14210","DOI":"10.1111\/acel.14210","volume":"23","author":"X Lu","year":"2024","unstructured":"Lu X, Li D, Lin Z, Gao T, Gong Z, Zhang Y, et al. HIF-1alpha-induced expression of the m6A reader YTHDF1 inhibits the ferroptosis of nucleus pulposus cells by promoting SLC7A11 translation. Aging Cell. 2024;23(9):e14210.","journal-title":"Aging Cell"},{"issue":"5","key":"1700_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","volume":"79","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu L, Liang C, Huang X, Liu Z, Huo J, et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol. 2023;79(5):1185\u2013200.","journal-title":"J Hepatol"},{"key":"1700_CR15","doi-asserted-by":"publisher","first-page":"132582","DOI":"10.1016\/j.jhazmat.2023.132582","volume":"461","author":"P Wang","year":"2024","unstructured":"Wang P, Xie D, Xiao T, Cheng C, Wang D, Sun J, et al. H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1\/m6A\/NREP. J Hazard Mater. 2024;461:132582.","journal-title":"J Hazard Mater"},{"issue":"22","key":"1700_CR16","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.18632\/aging.205253","volume":"15","author":"T Cui","year":"2023","unstructured":"Cui T, Lan Y, Yu F, Lin S, Qiu J. Plumbagin alleviates temporomandibular joint osteoarthritis progression by inhibiting chondrocyte ferroptosis via the MAPK signaling pathways. Aging (Albany NY). 2023;15(22):13452\u201370.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"1700_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389557520666201116144421","volume":"21","author":"A Roy","year":"2021","unstructured":"Roy A. Plumbagin: a potential anti-cancer compound. Mini Rev Med Chem. 2021;21(6):731\u20137.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"1700_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13048-022-01058-1","volume":"15","author":"Z Cai","year":"2022","unstructured":"Cai Z, He S, Liu R, Zhou L, Zhao L. Plumbagin rescues the granulosa cell\u2019s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome. J Ovarian Res. 2022;15(1):126.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1700_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/19768354.2020.1790416","volume":"24","author":"Z Cai","year":"2020","unstructured":"Cai Z, He S, Li T, Zhao L, Zhang K. Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K\/Akt\/mTOR pathway. Anim Cells Syst (Seoul). 2020;24(4):197\u2013204.","journal-title":"Anim Cells Syst (Seoul)"},{"issue":"8","key":"1700_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225\u201333.","journal-title":"Nat Med"},{"issue":"1","key":"1700_CR21","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1152\/ajpendo.00006.2020","volume":"319","author":"S Yi","year":"2020","unstructured":"Yi S, Zheng B, Zhu Y, Cai Y, Sun H, Zhou J. Melatonin ameliorates excessive PINK1\/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS. Am J Physiol Endocrinol Metab. 2020;319(1):E91\u2013101.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1700_CR22","doi-asserted-by":"publisher","first-page":"6986445","DOI":"10.1155\/2022\/6986445","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen W, Yang W, Zhang C, Liu T, Zhu J, Wang H, et al. Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10. Oxid Med Cell Longev. 2022;2022:6986445.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1700_CR23","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48(7):3816\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1700_CR24","doi-asserted-by":"publisher","first-page":"787854","DOI":"10.3389\/fendo.2021.787854","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhang L, Wei N, Tai Z, Yu C, Xu Z. Research Progress on the effect of epilepsy and antiseizure medications on PCOS through HPO axis. Front Endocrinol (Lausanne). 2021;12:787854.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1700_CR25","first-page":"699","volume":"39","author":"F Wang","year":"2017","unstructured":"Wang F, Zhang ZH, Xiao KZ, Wang ZC. Roles of hypothalamic-pituitary-adrenal axis and hypothalamus-pituitary-ovary axis in the abnormal endocrine functions in patients with polycystic ovary syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39(5):699\u2013704.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"1700_CR26","doi-asserted-by":"publisher","first-page":"101886","DOI":"10.1016\/j.redox.2021.101886","volume":"41","author":"T Li","year":"2021","unstructured":"Li T, Zhang T, Gao H, Liu R, Gu M, Yang Y, et al. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction. Redox Biol. 2021;41:101886.","journal-title":"Redox Biol"},{"key":"1700_CR27","doi-asserted-by":"publisher","first-page":"865748","DOI":"10.3389\/fendo.2022.865748","volume":"13","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zheng L, Wang Y, Gao Y, Xu Y. Arachidonic acid in follicular fluid of pcos induces oxidative stress in a human ovarian granulosa tumor cell line (KGN) and upregulates GDF15 expression as a response. Front Endocrinol (Lausanne). 2022;13:865748.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1700_CR28","doi-asserted-by":"publisher","first-page":"11749","DOI":"10.1038\/s41598-019-48037-z","volume":"9","author":"A Macone","year":"2019","unstructured":"Macone A, Masciarelli S, Palombarini F, Quaglio D, Boffi A, Trabuco MC, et al. Ferritin nanovehicle for targeted delivery of cytochrome C to cancer cells. Sci Rep. 2019;9(1):11749.","journal-title":"Sci Rep"},{"key":"1700_CR29","doi-asserted-by":"publisher","first-page":"112730","DOI":"10.1016\/j.jinorgbio.2024.112730","volume":"262","author":"DL Rousseau","year":"2025","unstructured":"Rousseau DL, Ishigami I, Yeh SR. Structural and functional mechanisms of cytochrome c oxidase. J Inorg Biochem. 2025;262:112730.","journal-title":"J Inorg Biochem"},{"issue":"4","key":"1700_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","volume":"31","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Arroum T, Luo X, Kang R, Lee YJ, Tang D, et al. Diverse functions of cytochrome c in cell death and disease. Cell Death Differ. 2024;31(4):387\u2013404.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1700_CR31","doi-asserted-by":"publisher","first-page":"115130","DOI":"10.1016\/j.celrep.2024.115130","volume":"44","author":"KN Dunlap","year":"2025","unstructured":"Dunlap KN, Bender A, Bowles A, Bott AJ, Tay J, Grossmann AH, et al. SLC7A5 is required for cancer cell growth under arginine-limited conditions. Cell Rep. 2025;44(1):115130.","journal-title":"Cell Rep"},{"issue":"1","key":"1700_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/or.2021.8228","volume":"47","author":"R Tornroos","year":"2022","unstructured":"Tornroos R, Tina E, Gothlin Eremo A. SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen-receptor-positive breast cancer. Oncol Rep. 2022;47(1):17.","journal-title":"Oncol Rep."},{"issue":"1","key":"1700_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12964-024-01826-0","volume":"22","author":"B Yang","year":"2024","unstructured":"Yang B, Wang Z, Niu K, Li T, Tong T, Li S, et al. TRIM35 triggers cardiac remodeling by regulating SLC7A5-mediated amino acid transport and mTORC1 activation in fibroblasts. Cell Commun Signal. 2024;22(1):444.","journal-title":"Cell Commun Signal"},{"issue":"13","key":"1700_CR34","doi-asserted-by":"publisher","first-page":"e18386","DOI":"10.1111\/jcmm.18386","volume":"28","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wei J, Sun H, Xu L. Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K\/AKT\/mTOR and Keap1-Nrf2\/HO-1 signalling pathways. J Cell Mol Med. 2024;28(13):e18386.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1700_CR35","doi-asserted-by":"publisher","first-page":"101767","DOI":"10.1016\/j.jbc.2022.101767","volume":"298","author":"G Shen","year":"2022","unstructured":"Shen G, Liu X, Lei W, Duan R, Yao Z. Plumbagin is a NF-kappaB-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice. J Biol Chem. 2022;298(4):101767.","journal-title":"J Biol Chem"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01700-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:11:11Z","timestamp":1748841071000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01700-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01700-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University (No. 2023\u2013100-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}